# Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients

> **NCT00421473** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 79 (actual)

## Conditions studied

- HIV Infections
- Malaria

## Interventions

- **DRUG:** Atovaquone / Proguanil

## Key facts

- **NCT ID:** NCT00421473
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2020-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421473, "Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00421473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*